Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine
Saved in:
Main Authors: | Évelyne Vinet, Sasha Bernatsky, Christian A Pineau, Fares Kalache, Louis-Pierre Grenier, Francisca Lambert-Fliszar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/8/1/e000519.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medication-related hospitalisations in patients with SLE
by: Arielle Mendel, et al.
Published: (2025-01-01) -
Marital status and age of systemic lupus erythematous diagnosis: the potential for differences related to sex and gender
by: Évelyne Vinet, et al.
Published: (2019-12-01) -
Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study
by: Mervat M. Alsous, et al.
Published: (2020-01-01) -
Managing Azathioprine-Induced Myelosuppression and Alopecia Totalis: Lessons from a SLE Patient
by: Saumya Dinithi Rupasinghe, et al.
Published: (2024-01-01) -
The Determination of Partition Coefficient of 6-Mercaptopurine Derivatives by Thin Layer Chromatography
by: Andrzej Czyrski, et al.
Published: (2013-01-01)